These findings are consistent with recent studies, which report MAGE-A9 overexpression in breast cancer [44–45] and bladder cancer [43] and identify MAGE-A9-enhanced tumorigenicity and tumor growth. This evidence concerns the gene MAGEA9 and breast cancer.